Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors
Clinical trial NCT03988283 · RECRUITING
Trial details
- NCT number
- NCT03988283
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-02
- Primary completion
- 2029-03-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.